We've found
1,865
archived clinical trials in
Multiple Sclerosis
We've found
1,865
archived clinical trials in
Multiple Sclerosis
Resilience-Based Program for Support Partners of Persons With Multiple Sclerosis
Updated: 12/31/1969
A Pilot Single-Center Study of a Manualized Resilience-Based Telehealth Program for Support Partners of Persons With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Resilience-Based Program for Support Partners of Persons With Multiple Sclerosis
Updated: 12/31/1969
A Pilot Single-Center Study of a Manualized Resilience-Based Telehealth Program for Support Partners of Persons With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Digital Cognition in Multiple Sclerosis
Updated: 12/31/1969
Effect of a Digital Therapeutic on Processing Speed in Adults With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Digital Cognition in Multiple Sclerosis
Updated: 12/31/1969
Effect of a Digital Therapeutic on Processing Speed in Adults With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Transcranial Direct Current Stimulation to Lower Neuropathic Pain in People With Multiple Sclerosis
Updated: 12/31/1969
Transcranial Direct Current Stimulation to Lower Neuropathic Pain in People With Multiple Sclerosis: a Mechanistic FDG-PET Study
Status: Enrolling
Updated: 12/31/1969
Transcranial Direct Current Stimulation to Lower Neuropathic Pain in People With Multiple Sclerosis
Updated: 12/31/1969
Transcranial Direct Current Stimulation to Lower Neuropathic Pain in People With Multiple Sclerosis: a Mechanistic FDG-PET Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Gene Expression Profiles in Multiple Sclerosis (MS)
Updated: 12/31/1969
Gene Expression Profiles in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Gene Expression Profiles in Multiple Sclerosis (MS)
Updated: 12/31/1969
Gene Expression Profiles in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Telephone-Delivered Exercise for Multiple Sclerosis Fatigue
Updated: 12/31/1969
Telephone-Delivered Interventions to Target Multiple Sclerosis Fatigue
Status: Enrolling
Updated: 12/31/1969
Telephone-Delivered Exercise for Multiple Sclerosis Fatigue
Updated: 12/31/1969
Telephone-Delivered Interventions to Target Multiple Sclerosis Fatigue
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Tecfidera and MRI for Brain Energy in MS
Updated: 12/31/1969
Modulation of Cerebral Grey Matter High Energy Phosphate Metabolites in Multiple Sclerosis by Dimethyl Fumarate
Status: Enrolling
Updated: 12/31/1969
Tecfidera and MRI for Brain Energy in MS
Updated: 12/31/1969
Modulation of Cerebral Grey Matter High Energy Phosphate Metabolites in Multiple Sclerosis by Dimethyl Fumarate
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis
Updated: 12/31/1969
Comparing Gastrointestinal Tolerability and Absorption of Racemic Lipoic Acid and R-lipoic Acid in Progressive Multiple Sclerosis: a Randomized Crossover Trial
Status: Enrolling
Updated: 12/31/1969
Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis
Updated: 12/31/1969
Comparing Gastrointestinal Tolerability and Absorption of Racemic Lipoic Acid and R-lipoic Acid in Progressive Multiple Sclerosis: a Randomized Crossover Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
LSFG-SKIN, Laser Speckle Flowgraphy
Updated: 12/31/1969
LSFG-SKIN, Laser Speckle Flowgraphy
Status: Enrolling
Updated: 12/31/1969
LSFG-SKIN, Laser Speckle Flowgraphy
Updated: 12/31/1969
LSFG-SKIN, Laser Speckle Flowgraphy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Intervention to Reduce Perceived Cognitive Impairment in Multiple Sclerosis
Updated: 12/31/1969
Intervention to Reduce Distress From Perceived Cognitive Impairment in Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Intervention to Reduce Perceived Cognitive Impairment in Multiple Sclerosis
Updated: 12/31/1969
Intervention to Reduce Distress From Perceived Cognitive Impairment in Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects
Updated: 12/31/1969
Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With Parkinson Disease or Alzheimer Disease and in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects
Updated: 12/31/1969
Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With Parkinson Disease or Alzheimer Disease and in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis
Updated: 9/14/2005
A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis.
Status: Enrolling
Updated: 9/14/2005
A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis
Updated: 9/14/2005
A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis.
Status: Enrolling
Updated: 9/14/2005
Click here to add this to my saved trials
Effects of Spinal Cord Injury on Female Sexual Response
Updated: 10/13/2006
Effects of SCI on Female Sexual Response
Status: Enrolling
Updated: 10/13/2006
Effects of Spinal Cord Injury on Female Sexual Response
Updated: 10/13/2006
Effects of SCI on Female Sexual Response
Status: Enrolling
Updated: 10/13/2006
Click here to add this to my saved trials
Whole Body Vibration Therapy in Participants With MS Related Balance Deficits
Updated: 8/1/2007
Whole Body Vibration Therapy in Participants With MS Related Balance Deficits
Status: Enrolling
Updated: 8/1/2007
Whole Body Vibration Therapy in Participants With MS Related Balance Deficits
Updated: 8/1/2007
Whole Body Vibration Therapy in Participants With MS Related Balance Deficits
Status: Enrolling
Updated: 8/1/2007
Click here to add this to my saved trials
Whole Body Vibration Therapy in Participants With MS Related Balance Deficits
Updated: 8/1/2007
Whole Body Vibration Therapy in Participants With MS Related Balance Deficits
Status: Enrolling
Updated: 8/1/2007
Whole Body Vibration Therapy in Participants With MS Related Balance Deficits
Updated: 8/1/2007
Whole Body Vibration Therapy in Participants With MS Related Balance Deficits
Status: Enrolling
Updated: 8/1/2007
Click here to add this to my saved trials
Teleconference Fatigue Management for People With MS
Updated: 12/26/2007
Effectiveness of a Teleconference Delivered Fatigue Management Program for People With Multiple Sclerosis
Status: Enrolling
Updated: 12/26/2007
Teleconference Fatigue Management for People With MS
Updated: 12/26/2007
Effectiveness of a Teleconference Delivered Fatigue Management Program for People With Multiple Sclerosis
Status: Enrolling
Updated: 12/26/2007
Click here to add this to my saved trials
Phase II High-Dose Cyclophosphamide for Multiple Sclerosis
Updated: 7/21/2009
Phase II Trial of High-dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis
Status: Enrolling
Updated: 7/21/2009
Phase II High-Dose Cyclophosphamide for Multiple Sclerosis
Updated: 7/21/2009
Phase II Trial of High-dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis
Status: Enrolling
Updated: 7/21/2009
Click here to add this to my saved trials
Safety of Polyphenon E in Multiple Sclerosis Pilot Study
Updated: 8/13/2009
Safety and Neuroprotective Effects of Polyphenon E in Multiple Sclerosis
Status: Enrolling
Updated: 8/13/2009
Safety of Polyphenon E in Multiple Sclerosis Pilot Study
Updated: 8/13/2009
Safety and Neuroprotective Effects of Polyphenon E in Multiple Sclerosis
Status: Enrolling
Updated: 8/13/2009
Click here to add this to my saved trials
Low Fat Diet and Multiple Sclerosis
Updated: 8/20/2010
A Randomized, Controlled Study of Diet and Multiple Sclerosis
Status: Enrolling
Updated: 8/20/2010
Low Fat Diet and Multiple Sclerosis
Updated: 8/20/2010
A Randomized, Controlled Study of Diet and Multiple Sclerosis
Status: Enrolling
Updated: 8/20/2010
Click here to add this to my saved trials
Evaluation of Angioplasty in the Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis
Updated: 9/20/2010
The Effectiveness of Endovascular Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 9/20/2010
Evaluation of Angioplasty in the Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis
Updated: 9/20/2010
The Effectiveness of Endovascular Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 9/20/2010
Click here to add this to my saved trials
Evaluation of Angioplasty in the Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis
Updated: 9/20/2010
The Effectiveness of Endovascular Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 9/20/2010
Evaluation of Angioplasty in the Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis
Updated: 9/20/2010
The Effectiveness of Endovascular Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 9/20/2010
Click here to add this to my saved trials
Head Circumference Growth in Children Who Develop Multiple Sclerosis Later in Life
Updated: 6/20/2011
Head Circumference Growth in Children Who Develop Multiple Sclerosis Later in Life -- a Retrospective Analysis
Status: Enrolling
Updated: 6/20/2011
Head Circumference Growth in Children Who Develop Multiple Sclerosis Later in Life
Updated: 6/20/2011
Head Circumference Growth in Children Who Develop Multiple Sclerosis Later in Life -- a Retrospective Analysis
Status: Enrolling
Updated: 6/20/2011
Click here to add this to my saved trials
Improving Hand Use in Multiple Sclerosis
Updated: 7/19/2011
Rehabilitating Extremity Use After Multiple Sclerosis
Status: Enrolling
Updated: 7/19/2011
Improving Hand Use in Multiple Sclerosis
Updated: 7/19/2011
Rehabilitating Extremity Use After Multiple Sclerosis
Status: Enrolling
Updated: 7/19/2011
Click here to add this to my saved trials
Mindfulness Based Stress Reduction in Multiple Sclerosis (MS)
Updated: 8/16/2011
Mindfulness Based Stress Reduction in MS
Status: Enrolling
Updated: 8/16/2011
Mindfulness Based Stress Reduction in Multiple Sclerosis (MS)
Updated: 8/16/2011
Mindfulness Based Stress Reduction in MS
Status: Enrolling
Updated: 8/16/2011
Click here to add this to my saved trials
Dalfampridine for Imbalance in Multiple Sclerosis
Updated: 10/6/2011
Dalfampridine to Improve Imbalance in Multiple Sclerosis: A Pilot Study
Status: Enrolling
Updated: 10/6/2011
Dalfampridine for Imbalance in Multiple Sclerosis
Updated: 10/6/2011
Dalfampridine to Improve Imbalance in Multiple Sclerosis: A Pilot Study
Status: Enrolling
Updated: 10/6/2011
Click here to add this to my saved trials
A Study to Test the Use of Duloxetine for Pain in MS
Updated: 10/11/2011
A Randomized Placebo Controlled Trial of Duloxetine for Central Pain in Multiple Sclerosis
Status: Enrolling
Updated: 10/11/2011
A Study to Test the Use of Duloxetine for Pain in MS
Updated: 10/11/2011
A Randomized Placebo Controlled Trial of Duloxetine for Central Pain in Multiple Sclerosis
Status: Enrolling
Updated: 10/11/2011
Click here to add this to my saved trials
Safety and Neuroprotective Effects of Polyphenon E in MS; Phase II
Updated: 10/13/2011
Phase 2 Randomized Placebo Controlled Trial of Polyphenon E in MS
Status: Enrolling
Updated: 10/13/2011
Safety and Neuroprotective Effects of Polyphenon E in MS; Phase II
Updated: 10/13/2011
Phase 2 Randomized Placebo Controlled Trial of Polyphenon E in MS
Status: Enrolling
Updated: 10/13/2011
Click here to add this to my saved trials
Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis
Updated: 1/24/2012
Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis
Status: Enrolling
Updated: 1/24/2012
Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis
Updated: 1/24/2012
Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis
Status: Enrolling
Updated: 1/24/2012
Click here to add this to my saved trials
Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis
Updated: 1/24/2012
Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis
Status: Enrolling
Updated: 1/24/2012
Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis
Updated: 1/24/2012
Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis
Status: Enrolling
Updated: 1/24/2012
Click here to add this to my saved trials
A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis
Updated: 2/24/2012
A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis
Status: Enrolling
Updated: 2/24/2012
A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis
Updated: 2/24/2012
A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis
Status: Enrolling
Updated: 2/24/2012
Click here to add this to my saved trials
Promoting Physical Activity Behavior in Persons With Multiple Sclerosis
Updated: 4/4/2012
Using Targeted Print-material to Promote Physical Activity Behavior in Adults With Multiple Sclerosis
Status: Enrolling
Updated: 4/4/2012
Promoting Physical Activity Behavior in Persons With Multiple Sclerosis
Updated: 4/4/2012
Using Targeted Print-material to Promote Physical Activity Behavior in Adults With Multiple Sclerosis
Status: Enrolling
Updated: 4/4/2012
Click here to add this to my saved trials
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Updated: 4/18/2012
Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA)
Status: Enrolling
Updated: 4/18/2012
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Updated: 4/18/2012
Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA)
Status: Enrolling
Updated: 4/18/2012
Click here to add this to my saved trials
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Updated: 4/18/2012
Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA)
Status: Enrolling
Updated: 4/18/2012
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Updated: 4/18/2012
Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA)
Status: Enrolling
Updated: 4/18/2012
Click here to add this to my saved trials
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Updated: 4/18/2012
Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA)
Status: Enrolling
Updated: 4/18/2012
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Updated: 4/18/2012
Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA)
Status: Enrolling
Updated: 4/18/2012
Click here to add this to my saved trials
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Updated: 4/18/2012
Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA)
Status: Enrolling
Updated: 4/18/2012
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Updated: 4/18/2012
Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA)
Status: Enrolling
Updated: 4/18/2012
Click here to add this to my saved trials
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Updated: 4/18/2012
Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA)
Status: Enrolling
Updated: 4/18/2012
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Updated: 4/18/2012
Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA)
Status: Enrolling
Updated: 4/18/2012
Click here to add this to my saved trials
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Updated: 4/18/2012
Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA)
Status: Enrolling
Updated: 4/18/2012
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Updated: 4/18/2012
Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA)
Status: Enrolling
Updated: 4/18/2012
Click here to add this to my saved trials
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Updated: 4/18/2012
Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA)
Status: Enrolling
Updated: 4/18/2012
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Updated: 4/18/2012
Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA)
Status: Enrolling
Updated: 4/18/2012
Click here to add this to my saved trials
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Updated: 4/18/2012
Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA)
Status: Enrolling
Updated: 4/18/2012
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Updated: 4/18/2012
Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA)
Status: Enrolling
Updated: 4/18/2012
Click here to add this to my saved trials
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Updated: 4/18/2012
Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA)
Status: Enrolling
Updated: 4/18/2012
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Updated: 4/18/2012
Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA)
Status: Enrolling
Updated: 4/18/2012
Click here to add this to my saved trials
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Updated: 4/18/2012
Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA)
Status: Enrolling
Updated: 4/18/2012
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Updated: 4/18/2012
Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA)
Status: Enrolling
Updated: 4/18/2012
Click here to add this to my saved trials
TakeCharge: Telephone Delivered Self-management Intervention for People With Multiple Sclerosis (MS)
Updated: 6/19/2012
Telephone Delivered Self-management Intervention for People With Multiple Sclerosis Addressing Pain, Fatigue, Depression, and Cognitive Difficulties
Status: Enrolling
Updated: 6/19/2012
TakeCharge: Telephone Delivered Self-management Intervention for People With Multiple Sclerosis (MS)
Updated: 6/19/2012
Telephone Delivered Self-management Intervention for People With Multiple Sclerosis Addressing Pain, Fatigue, Depression, and Cognitive Difficulties
Status: Enrolling
Updated: 6/19/2012
Click here to add this to my saved trials
inMotion Clinical Study: Using Motivational Interviewing to Increase Physical Activity to Treat Depression in People Aging With MS or SCI
Updated: 6/19/2012
The Effectiveness of Physical Activity for Major Depression in People Aging With Multiple Sclerosis or Spinal Cord Injury
Status: Enrolling
Updated: 6/19/2012
inMotion Clinical Study: Using Motivational Interviewing to Increase Physical Activity to Treat Depression in People Aging With MS or SCI
Updated: 6/19/2012
The Effectiveness of Physical Activity for Major Depression in People Aging With Multiple Sclerosis or Spinal Cord Injury
Status: Enrolling
Updated: 6/19/2012
Click here to add this to my saved trials
Functional and Physiological Responses to Lokomat Therapy (Pilot Study)
Updated: 6/21/2012
Functional and Physiological Responses to Lokomat Therapy (Pilot Study)
Status: Enrolling
Updated: 6/21/2012
Functional and Physiological Responses to Lokomat Therapy (Pilot Study)
Updated: 6/21/2012
Functional and Physiological Responses to Lokomat Therapy (Pilot Study)
Status: Enrolling
Updated: 6/21/2012
Click here to add this to my saved trials
Continuous Positive Airway Pressure (CPAP) for Fatigue in Patients With Multiple Sclerosis (MS) and Obstructive Sleep Apnea (OSA)
Updated: 8/20/2012
Continuous Positive Airway Pressure for Fatigue Treatment in Patients With Multiple Sclerosis and Obstructive Sleep Apnea
Status: Enrolling
Updated: 8/20/2012
Continuous Positive Airway Pressure (CPAP) for Fatigue in Patients With Multiple Sclerosis (MS) and Obstructive Sleep Apnea (OSA)
Updated: 8/20/2012
Continuous Positive Airway Pressure for Fatigue Treatment in Patients With Multiple Sclerosis and Obstructive Sleep Apnea
Status: Enrolling
Updated: 8/20/2012
Click here to add this to my saved trials
A Longitudinal Study of Effect of Copaxone in RRMS Over 24 Months
Updated: 9/27/2012
A Prospective, Observational, Single-blinded, Longitudinal MRI Study of Effect of Glatiramer Acetate on Iron Deposition in Patients With Relapsing-remitting Multiple Sclerosis Over 24 Months
Status: Enrolling
Updated: 9/27/2012
A Longitudinal Study of Effect of Copaxone in RRMS Over 24 Months
Updated: 9/27/2012
A Prospective, Observational, Single-blinded, Longitudinal MRI Study of Effect of Glatiramer Acetate on Iron Deposition in Patients With Relapsing-remitting Multiple Sclerosis Over 24 Months
Status: Enrolling
Updated: 9/27/2012
Click here to add this to my saved trials
Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients With Multiple Sclerosis Taking Glatiramer Acetate
Updated: 12/13/2012
Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients With Multiple Sclerosis Taking Glatiramer Acetate: A Randomized Controlled Double- Blind Crossover Trial
Status: Enrolling
Updated: 12/13/2012
Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients With Multiple Sclerosis Taking Glatiramer Acetate
Updated: 12/13/2012
Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients With Multiple Sclerosis Taking Glatiramer Acetate: A Randomized Controlled Double- Blind Crossover Trial
Status: Enrolling
Updated: 12/13/2012
Click here to add this to my saved trials
Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active Control
Updated: 12/14/2012
Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in a Natalizumab Treated Population With Active Control Assessment
Status: Enrolling
Updated: 12/14/2012
Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active Control
Updated: 12/14/2012
Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in a Natalizumab Treated Population With Active Control Assessment
Status: Enrolling
Updated: 12/14/2012
Click here to add this to my saved trials
Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis
Updated: 1/15/2013
Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis
Status: Enrolling
Updated: 1/15/2013
Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis
Updated: 1/15/2013
Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis
Status: Enrolling
Updated: 1/15/2013
Click here to add this to my saved trials
Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis
Updated: 1/15/2013
Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis
Status: Enrolling
Updated: 1/15/2013
Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis
Updated: 1/15/2013
Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis
Status: Enrolling
Updated: 1/15/2013
Click here to add this to my saved trials